Management tracks: Ascletis, Agenus

Antiviral company Ascletis Pharma Inc. (HKSE:1672) hired Lindi Tan as CFO. She was a global healthcare analyst at SeaTown Holdings International. Ascletis was the first biotech to go public on the Hong Kong stock exchange's new prerevenue chapter.

Agenus Inc. (NASDAQ:AGEN) named Jennifer Buell COO. She was chief communications and external affairs officer at the immuno-oncology company.
Nektar Therapeutics (NASDAQ:NKTR) hired Wei Lin as SVP of clinical development and head of the biotech’s oncology programs. He was global development leader for cancer immunotherapy in lung and head and neck cancer at Genentech Inc...